Brought to you by:

Cell & Gene Therapy

Reorganization team change restructure
Biotech

Industry disappointed as FDA puts gene therapy chief on leave

The FDA has reportedly put the director of its cell and gene therapy office on administrative leave and escorted her out of the agency.
Nick Paul Taylor Jun 20, 2025 1:53am
Eli Lilly

Eli Lilly pays $1B upfront to buy gene editing partner Verve

Jun 17, 2025 4:35am
Redbrick building with Sarepta name and logo
Favicon Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Graphic of a drop of blood made up of small data points and nodes

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Jun 13, 2025 1:22pm
Close-up of human eye

SpliceBio secures $135M series B for eye gene therapy trials

Jun 11, 2025 3:00am
Berger

To Gilead's new CMO, pipeline diversification is key

Jun 9, 2025 10:00am
More News

As investors pivot from cell therapy, Immatics keeps the faith

Jun 6, 2025 3:50am

At cell and gene roundtable, officials pledge to slash regulations

Jun 5, 2025 2:50pm

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am

Cullinan's $700M pact for BCMA bispecific to pair with other TCE

Jun 5, 2025 4:38am